20 JANUARY 2011

NEW ZEALAND GAZETTE, No. 5

milligrams; in medicines for the treatment of the symptoms of cough and cold in children aged 6–12 years

Phenylephrine; for nasal use in medicines containing more than 1%; for ophthalmic use in medicines containing 5% or less and more than 1%; for oral use in medicines containing more than 50 milligrams per recommended daily dose or in packs containing more than 250 milligrams of phenylephrine per pack; in medicines for the treatment of the symptoms of cough and cold in children aged 6–12 years

Medicines for General Sale

Please note that the following medicines are now available for general sale.

Dextromethorphan; in liquid form containing 0.25% or less or in solid dose form containing 15 milligrams or less per dose form when in packs containing not more than 600 milligrams and with a recommended daily dose of not more than 120 milligrams; except in medicines for the treatment of the symptoms of cough and cold in children aged 6–12 years

Phenylephrine; for nasal or ophthalmic use in medicines containing 1% or less; for oral use in medicines containing 50 milligrams or less per recommended daily dose and in packs containing 250 milligrams or less of phenylephrine per pack; except in medicines for the treatment of the symptoms of cough and cold in children aged 6–12 years

Dated this 14th day of January 2011.

BARBARA PHILLIPS, Acting Deputy Director-General,
Population Health Directorate, Ministry of Health.

go267

Classification of Medicines

Pursuant to section 106(1) of the Medicines Act 1981, I, Barbara Phillips, Acting Deputy Director-General, Population Health Directorate, Ministry of Health, acting under delegated authority, hereby declare the following:

1. The medicines listed in Schedule 1 to this notice are classified as prescription medicines.

2. The medicines listed in Schedule 2 to this notice are classified as restricted medicines.

3. The medicines listed in Schedule 3 to this notice are classified as pharmacy-only medicines.

Every reference to a medicine in this notice applies whether the medicine is synthetic in origin or is from biological or mineral sources.

Unless specific reference is made otherwise, every reference applies also to medicines that are:

(a) preparations and admixtures containing any proportion of any substance listed in the notice.

(b) salts and esters of any substance listed in the notice.

(c) preparations or extracts of biological materials listed in the notice.

(d) salts or oxides of elements listed in the notice.

Unless specific reference is made otherwise, every reference to a medicine applies:

(i) if the medicine is in an injection or eye preparation, to any concentration of that medicine; and

(ii) if the medicine is not in an injection or eye preparation, only if the concentration of the medicine is greater than 10 milligrams per litre or per kilogram.

Where any reference is modified by a statement of the strength of the medicine, the strength is calculated using the free acid, base, alcohol or element unless specifically stated otherwise.

Schedule 1

Prescription Medicines

Amyl nitrite; except when sold to a person who holds a valid Controlled Substances Licence authorising them to possess cyanide

Calcipotriol; except in medicines containing not more than 50 micrograms per gram or per millilitre and when sold in a pack of not more than 30 grams or 30 millilitres by a pharmacist to an adult with mild to moderate psoriasis previously diagnosed by a doctor

Chloramphenicol; except when sold in practice by a registered optometrist; except when specified elsewhere in this notice

Codeine; except when specified elsewhere in this notice

Corifollitropin alfa

Famciclovir; except when specified elsewhere in this notice

Fexofenadine; except for oral use

Fluorides; for internal use in medicines containing more than 0.5 milligrams per dose unit except in medicines containing 15 milligrams or less per litre or per kilogram; except in parenteral nutrition replacement preparations; for external use in medicines containing more than 5500 milligrams per litre or per kilogram except when supplied to a dental professional recognised by the Dental Council of New Zealand

Heparins; for internal use; except when present as an excipient

Human papillomavirus vaccine

Ibogaine

Japanese encephalitis vaccine

Lansoprazole; except when specified elsewhere in this notice

Loperamide; except when specified elsewhere in this notice

Nebivolol

Noribogaine

Omeprazole; except when specified elsewhere in this notice

Pazopanib

Phosphodiesterase type 5 inhibitors; except when present as an unmodified, naturally occurring substance; except when specified elsewhere in this notice

Rizatriptan; except when specified elsewhere in this notice

Roflumilast

Saxagliptin

Staphylococcus aureus vaccine; except in oral vaccines for the prophylaxis of bacterial complications of colds

Stramonium; except for oral use when specified elsewhere in this notice; except datura stramonium or datura tatula for smoking or burning

Streptococcus beta-haemolyticus vaccine; except in oral vaccines for the prophylaxis of bacterial complications of colds

Succimer

Tapentadol

Ustekinumab

Vaccines; except when specified elsewhere in this notice

Vaccinia virus vaccine

Vernakalant

Vinflunine

Zolmitriptan; except when specified elsewhere in this notice

Schedule 2

Restricted Medicines

Chloramphenicol; for ophthalmic use; except when sold in practice by a registered optometrist